BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, February 7, 2026
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for June 29, 2021

June 29, 2021
Biopharmas raising money in public or private financings, including: AB Science, Aligos, Biovaxys, Celcuity, Elicio, FS, Inmed, Intellia, Kymera, Modus, Oncoinvent, Pardes, Regenerx, Zentalis.
Read More
Surgeon at Versius console

CMR Surgical continues record-breaking pace with $600M series D funding

June 28, 2021
By Nuala Moran
LONDON – CMR Surgical Ltd. has once again broken the record for a private financing round by a European med-tech company, raising $600 million in a series D funding round. That follows on from two other record-breaking rounds, in which the Cambridge, U.K.-based CMR raised $240 million in a series C in September 2019 and $100 million in the series B round that closed in May 2018. These earlier rounds enabled CMR to complete development and install the first commercial versions of its Versius surgical robots. Now the series D will push the company through to profitability, the company said.
Read More

Financings for June 28, 2021

June 28, 2021
Med-tech firms raising money in public or private financings, including: Applied UV, Palliare, Second Sight Medical Products.
Read More

Financings for June 28, 2021

June 28, 2021
Biopharmas raising money in public or private financings, including: Candel, Eikonoklastes, Erasca, Sanyou.
Read More

Financings for June 25, 2021

June 25, 2021
Med-tech firms raising money in public or private financings, including: G Medical Innovations, Nyxoah, Teknova.
Read More
IPO line graph

Graphite, Elevation, GH Research continue 2021 IPO rush

June 25, 2021
By Michael Fitzhugh
Maintaining momentum for a rush of 2021 IPOs already on pace to beat 2020's record number, new offerings from Graphite Bio Inc., GH Research plc and Elevation Oncology Inc. raised nearly $500 million altogether on Friday. While shares of the first two fared well, climbing in their debuts, Elevation's shares (NASDAQ:ELEV) fell from $16 debut to $11.44 at the close, a 28.5% decline.
Read More

Financings for June 25, 2021

June 25, 2021
Biopharmas raising money in public or private financings, including: Anavex Life Sciences, Betterlife, Genfit, Orion, Theravance.
Read More

Financings for June 24, 2021

June 24, 2021
Med-tech firms raising money in public or private financings, including: Arya Sciences, Cardiac Success, Doximity, Miromatrix Medical, Otolith, Triastek.
Read More
Arjun Goyal, co-founder and managing director, Vida Ventures

Arie Belldegrun’s Vida Ventures snaps up $825M to spend on cutting-edge R&D

June 24, 2021
By Richard Staines
Vida Ventures, the venture capital firm co-founded by CAR T pioneer Arie Belldegrun, has closed an oversubscribed $825 million fund, bringing the total amount of assets under management to more than $1.7 billion.
Read More

Financings for June 24, 2021

June 24, 2021
Biopharmas raising money in public or private financings, including: Acumen, Aerovate, Arya, Gliknik, Lyndra, Karyopharm, Monte Rosa, Phoenix Pharmalabs, Portage, Triastek.
Read More
Previous 1 2 … 450 451 452 453 454 455 456 457 458 … 651 652 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Feb. 6, 2025.
  • Brain illustration

    MJFF grant supports Bexorg’s translational biomarker work

    BioWorld Science
    Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
  • Brain and DNA

    REST emerges as biomarker in ALS, knockdown improves ALS symptoms

    BioWorld Science
    About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
  • Brain illustrated with pills

    Serotonin receptor modulators for the treatment of OUD

    BioWorld Science
    Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
  • Liver anatomy illustration

    KLF15 shows potential as marker, target for cholangiocarcinoma

    BioWorld Science
    Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing